nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—CYP2E1—type 2 diabetes mellitus	0.247	0.614	CbGaD
Metyrapone—CYP3A4—type 2 diabetes mellitus	0.156	0.386	CbGaD
Metyrapone—ABCC3—Glyburide—type 2 diabetes mellitus	0.105	0.28	CbGbCtD
Metyrapone—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.084	0.224	CbGbCtD
Metyrapone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0282	0.0755	CbGbCtD
Metyrapone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0252	0.0673	CbGbCtD
Metyrapone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.023	0.0615	CbGbCtD
Metyrapone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0201	0.0538	CbGbCtD
Metyrapone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0182	0.0486	CbGbCtD
Metyrapone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0138	0.0368	CbGbCtD
Metyrapone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0132	0.0353	CbGbCtD
Metyrapone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0132	0.0353	CbGbCtD
Metyrapone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0125	0.0334	CbGbCtD
Metyrapone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00931	0.0249	CbGbCtD
Metyrapone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00852	0.0228	CbGbCtD
Metyrapone—Dermatitis atopic—Bromocriptine—type 2 diabetes mellitus	0.00195	0.0183	CcSEcCtD
Metyrapone—Pancytopenia—Tolbutamide—type 2 diabetes mellitus	0.00169	0.0159	CcSEcCtD
Metyrapone—Pancytopenia—Chlorpropamide—type 2 diabetes mellitus	0.00154	0.0145	CcSEcCtD
Metyrapone—Pancytopenia—Tolazamide—type 2 diabetes mellitus	0.00154	0.0145	CcSEcCtD
Metyrapone—White blood cell count decreased—Ramipril—type 2 diabetes mellitus	0.00152	0.0142	CcSEcCtD
Metyrapone—Angiopathy—Acarbose—type 2 diabetes mellitus	0.00113	0.0106	CcSEcCtD
Metyrapone—Bone marrow depression—Ramipril—type 2 diabetes mellitus	0.00112	0.0105	CcSEcCtD
Metyrapone—Abdominal discomfort—Glipizide—type 2 diabetes mellitus	0.00103	0.00968	CcSEcCtD
Metyrapone—Pancytopenia—Glipizide—type 2 diabetes mellitus	0.00102	0.00959	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.000973	0.00914	CcSEcCtD
Metyrapone—Abdominal discomfort—Sitagliptin—type 2 diabetes mellitus	0.00096	0.00901	CcSEcCtD
Metyrapone—Pancytopenia—Glimepiride—type 2 diabetes mellitus	0.000954	0.00895	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.000946	0.00888	CcSEcCtD
Metyrapone—Gastrointestinal pain—Miglitol—type 2 diabetes mellitus	0.000922	0.00865	CcSEcCtD
Metyrapone—Alopecia—Repaglinide—type 2 diabetes mellitus	0.00092	0.00864	CcSEcCtD
Metyrapone—Endocrine disorder—Ramipril—type 2 diabetes mellitus	0.000911	0.00855	CcSEcCtD
Metyrapone—Abdominal pain—Miglitol—type 2 diabetes mellitus	0.000891	0.00837	CcSEcCtD
Metyrapone—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.000887	0.00832	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.000875	0.00822	CcSEcCtD
Metyrapone—Abdominal discomfort—Bromocriptine—type 2 diabetes mellitus	0.000868	0.00815	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.000796	0.00748	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.000796	0.00748	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.000788	0.0074	CcSEcCtD
Metyrapone—Pancytopenia—Glyburide—type 2 diabetes mellitus	0.000786	0.00738	CcSEcCtD
Metyrapone—Hypertension—Repaglinide—type 2 diabetes mellitus	0.000782	0.00734	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.000766	0.00719	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.000765	0.00718	CcSEcCtD
Metyrapone—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.000739	0.00694	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.000738	0.00693	CcSEcCtD
Metyrapone—Angiopathy—Sitagliptin—type 2 diabetes mellitus	0.000727	0.00682	CcSEcCtD
Metyrapone—Gastrointestinal pain—Acarbose—type 2 diabetes mellitus	0.000725	0.0068	CcSEcCtD
Metyrapone—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.000718	0.00674	CcSEcCtD
Metyrapone—Abdominal discomfort—Gliclazide—type 2 diabetes mellitus	0.000713	0.00669	CcSEcCtD
Metyrapone—Pancytopenia—Gliclazide—type 2 diabetes mellitus	0.000706	0.00663	CcSEcCtD
Metyrapone—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.0007	0.00658	CcSEcCtD
Metyrapone—Gastrointestinal pain—Nateglinide—type 2 diabetes mellitus	0.000699	0.00656	CcSEcCtD
Metyrapone—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.000685	0.00644	CcSEcCtD
Metyrapone—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.000675	0.00634	CcSEcCtD
Metyrapone—Nausea—Miglitol—type 2 diabetes mellitus	0.00067	0.00629	CcSEcCtD
Metyrapone—Angiopathy—Bromocriptine—type 2 diabetes mellitus	0.000658	0.00618	CcSEcCtD
Metyrapone—Hypertension—Glipizide—type 2 diabetes mellitus	0.000647	0.00608	CcSEcCtD
Metyrapone—Abdominal discomfort—Orlistat—type 2 diabetes mellitus	0.000647	0.00608	CcSEcCtD
Metyrapone—Alopecia—Bromocriptine—type 2 diabetes mellitus	0.000641	0.00601	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.000638	0.00599	CcSEcCtD
Metyrapone—Headache—Tolbutamide—type 2 diabetes mellitus	0.000635	0.00596	CcSEcCtD
Metyrapone—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.00062	0.00582	CcSEcCtD
Metyrapone—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00061	0.00573	CcSEcCtD
Metyrapone—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00061	0.00573	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.000607	0.0057	CcSEcCtD
Metyrapone—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.000605	0.00568	CcSEcCtD
Metyrapone—Hypertension—Glimepiride—type 2 diabetes mellitus	0.000604	0.00567	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000603	0.00567	CcSEcCtD
Metyrapone—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000602	0.00565	CcSEcCtD
Metyrapone—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.000602	0.00565	CcSEcCtD
Metyrapone—Abdominal discomfort—Metformin—type 2 diabetes mellitus	0.000596	0.0056	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.00059	0.00554	CcSEcCtD
Metyrapone—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000586	0.00551	CcSEcCtD
Metyrapone—Alopecia—Glyburide—type 2 diabetes mellitus	0.000586	0.0055	CcSEcCtD
Metyrapone—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000585	0.00549	CcSEcCtD
Metyrapone—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000578	0.00542	CcSEcCtD
Metyrapone—Headache—Tolazamide—type 2 diabetes mellitus	0.000578	0.00542	CcSEcCtD
Metyrapone—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000575	0.0054	CcSEcCtD
Metyrapone—Headache—Linagliptin—type 2 diabetes mellitus	0.000572	0.00537	CcSEcCtD
Metyrapone—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000569	0.00535	CcSEcCtD
Metyrapone—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000565	0.0053	CcSEcCtD
Metyrapone—Vomiting—Acarbose—type 2 diabetes mellitus	0.000563	0.00529	CcSEcCtD
Metyrapone—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000558	0.00524	CcSEcCtD
Metyrapone—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000553	0.00519	CcSEcCtD
Metyrapone—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000548	0.00514	CcSEcCtD
Metyrapone—Nausea—Tolazamide—type 2 diabetes mellitus	0.000548	0.00514	CcSEcCtD
Metyrapone—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000545	0.00512	CcSEcCtD
Metyrapone—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000543	0.0051	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000534	0.00501	CcSEcCtD
Metyrapone—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000534	0.00501	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000528	0.00496	CcSEcCtD
Metyrapone—Nausea—Acarbose—type 2 diabetes mellitus	0.000526	0.00494	CcSEcCtD
Metyrapone—Pain—Glipizide—type 2 diabetes mellitus	0.000523	0.00491	CcSEcCtD
Metyrapone—Nausea—Nateglinide—type 2 diabetes mellitus	0.000508	0.00476	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000506	0.00475	CcSEcCtD
Metyrapone—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000505	0.00474	CcSEcCtD
Metyrapone—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.0005	0.0047	CcSEcCtD
Metyrapone—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.0005	0.0047	CcSEcCtD
Metyrapone—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000496	0.00466	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000493	0.00463	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000491	0.00461	CcSEcCtD
Metyrapone—Pain—Sitagliptin—type 2 diabetes mellitus	0.000487	0.00457	CcSEcCtD
Metyrapone—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000484	0.00454	CcSEcCtD
Metyrapone—Alopecia—Valsartan—type 2 diabetes mellitus	0.000483	0.00454	CcSEcCtD
Metyrapone—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000481	0.00452	CcSEcCtD
Metyrapone—Alopecia—Orlistat—type 2 diabetes mellitus	0.000477	0.00448	CcSEcCtD
Metyrapone—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00047	0.00441	CcSEcCtD
Metyrapone—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000467	0.00438	CcSEcCtD
Metyrapone—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000465	0.00437	CcSEcCtD
Metyrapone—Headache—Repaglinide—type 2 diabetes mellitus	0.000463	0.00435	CcSEcCtD
Metyrapone—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000462	0.00434	CcSEcCtD
Metyrapone—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000462	0.00434	CcSEcCtD
Metyrapone—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000454	0.00426	CcSEcCtD
Metyrapone—Angiopathy—Metformin—type 2 diabetes mellitus	0.000452	0.00424	CcSEcCtD
Metyrapone—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000451	0.00424	CcSEcCtD
Metyrapone—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00045	0.00422	CcSEcCtD
Metyrapone—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.00045	0.00422	CcSEcCtD
Metyrapone—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000447	0.0042	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000445	0.00417	CcSEcCtD
Metyrapone—Hypotension—Glyburide—type 2 diabetes mellitus	0.00044	0.00413	CcSEcCtD
Metyrapone—Nausea—Repaglinide—type 2 diabetes mellitus	0.000439	0.00412	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000438	0.00411	CcSEcCtD
Metyrapone—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000438	0.00411	CcSEcCtD
Metyrapone—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000426	0.004	CcSEcCtD
Metyrapone—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000421	0.00395	CcSEcCtD
Metyrapone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000415	0.0039	CcSEcCtD
Metyrapone—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000415	0.00389	CcSEcCtD
Metyrapone—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000411	0.00386	CcSEcCtD
Metyrapone—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000407	0.00382	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000407	0.00382	CcSEcCtD
Metyrapone—Dizziness—Glipizide—type 2 diabetes mellitus	0.000405	0.0038	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000402	0.00378	CcSEcCtD
Metyrapone—Angiopathy—Losartan—type 2 diabetes mellitus	0.000401	0.00377	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000398	0.00373	CcSEcCtD
Metyrapone—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000395	0.00371	CcSEcCtD
Metyrapone—Alopecia—Losartan—type 2 diabetes mellitus	0.000391	0.00367	CcSEcCtD
Metyrapone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000389	0.00365	CcSEcCtD
Metyrapone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000388	0.00364	CcSEcCtD
Metyrapone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000385	0.00361	CcSEcCtD
Metyrapone—Headache—Glipizide—type 2 diabetes mellitus	0.000383	0.0036	CcSEcCtD
Metyrapone—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000381	0.00358	CcSEcCtD
Metyrapone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000378	0.00354	CcSEcCtD
Metyrapone—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000377	0.00354	CcSEcCtD
Metyrapone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000376	0.00353	CcSEcCtD
Metyrapone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000376	0.00353	CcSEcCtD
Metyrapone—Hypertension—Metformin—type 2 diabetes mellitus	0.000374	0.00351	CcSEcCtD
Metyrapone—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000373	0.0035	CcSEcCtD
Metyrapone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000372	0.00349	CcSEcCtD
Metyrapone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000367	0.00345	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000367	0.00344	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000365	0.00343	CcSEcCtD
Metyrapone—Nausea—Glipizide—type 2 diabetes mellitus	0.000363	0.00341	CcSEcCtD
Metyrapone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000363	0.00341	CcSEcCtD
Metyrapone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000363	0.00341	CcSEcCtD
Metyrapone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000362	0.0034	CcSEcCtD
Metyrapone—Pain—Gliclazide—type 2 diabetes mellitus	0.000362	0.00339	CcSEcCtD
Metyrapone—Headache—Glimepiride—type 2 diabetes mellitus	0.000358	0.00336	CcSEcCtD
Metyrapone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000357	0.00335	CcSEcCtD
Metyrapone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000353	0.00332	CcSEcCtD
Metyrapone—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000347	0.00326	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000346	0.00325	CcSEcCtD
Metyrapone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000346	0.00325	CcSEcCtD
Metyrapone—Skin disorder—Metformin—type 2 diabetes mellitus	0.000344	0.00323	CcSEcCtD
Metyrapone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000341	0.0032	CcSEcCtD
Metyrapone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000339	0.00318	CcSEcCtD
Metyrapone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000338	0.00317	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000335	0.00315	CcSEcCtD
Metyrapone—Alopecia—Ramipril—type 2 diabetes mellitus	0.000335	0.00315	CcSEcCtD
Metyrapone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000334	0.00314	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000331	0.00311	CcSEcCtD
Metyrapone—Hypotension—Metformin—type 2 diabetes mellitus	0.000331	0.0031	CcSEcCtD
Metyrapone—Pain—Orlistat—type 2 diabetes mellitus	0.000328	0.00308	CcSEcCtD
Metyrapone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000328	0.00307	CcSEcCtD
Metyrapone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000327	0.00307	CcSEcCtD
Metyrapone—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000324	0.00304	CcSEcCtD
Metyrapone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000323	0.00303	CcSEcCtD
Metyrapone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000318	0.00298	CcSEcCtD
Metyrapone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000314	0.00295	CcSEcCtD
Metyrapone—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000312	0.00293	CcSEcCtD
Metyrapone—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000308	0.00289	CcSEcCtD
Metyrapone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000307	0.00288	CcSEcCtD
Metyrapone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000306	0.00287	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000305	0.00287	CcSEcCtD
Metyrapone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000303	0.00285	CcSEcCtD
Metyrapone—Vomiting—Glyburide—type 2 diabetes mellitus	0.000299	0.00281	CcSEcCtD
Metyrapone—Headache—Glyburide—type 2 diabetes mellitus	0.000295	0.00277	CcSEcCtD
Metyrapone—Hypotension—Losartan—type 2 diabetes mellitus	0.000294	0.00276	CcSEcCtD
Metyrapone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000289	0.00272	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000288	0.00271	CcSEcCtD
Metyrapone—Pain—Irbesartan—type 2 diabetes mellitus	0.000286	0.00268	CcSEcCtD
Metyrapone—Nausea—Glyburide—type 2 diabetes mellitus	0.00028	0.00263	CcSEcCtD
Metyrapone—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00028	0.00263	CcSEcCtD
Metyrapone—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00028	0.00262	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000279	0.00262	CcSEcCtD
Metyrapone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000273	0.00256	CcSEcCtD
Metyrapone—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000269	0.00252	CcSEcCtD
Metyrapone—Pain—Losartan—type 2 diabetes mellitus	0.000269	0.00252	CcSEcCtD
Metyrapone—Headache—Gliclazide—type 2 diabetes mellitus	0.000265	0.00249	CcSEcCtD
Metyrapone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000264	0.00248	CcSEcCtD
Metyrapone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000264	0.00248	CcSEcCtD
Metyrapone—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000262	0.00246	CcSEcCtD
Metyrapone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000257	0.00241	CcSEcCtD
Metyrapone—Dizziness—Valsartan—type 2 diabetes mellitus	0.000257	0.00241	CcSEcCtD
Metyrapone—Dizziness—Orlistat—type 2 diabetes mellitus	0.000254	0.00238	CcSEcCtD
Metyrapone—Hypotension—Ramipril—type 2 diabetes mellitus	0.000252	0.00236	CcSEcCtD
Metyrapone—Nausea—Gliclazide—type 2 diabetes mellitus	0.000251	0.00236	CcSEcCtD
Metyrapone—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000248	0.00233	CcSEcCtD
Metyrapone—Vomiting—Valsartan—type 2 diabetes mellitus	0.000247	0.00232	CcSEcCtD
Metyrapone—Vomiting—Orlistat—type 2 diabetes mellitus	0.000244	0.00229	CcSEcCtD
Metyrapone—Headache—Valsartan—type 2 diabetes mellitus	0.000243	0.00228	CcSEcCtD
Metyrapone—Headache—Orlistat—type 2 diabetes mellitus	0.00024	0.00226	CcSEcCtD
Metyrapone—Dizziness—Metformin—type 2 diabetes mellitus	0.000234	0.0022	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000233	0.00218	CcSEcCtD
Metyrapone—Nausea—Valsartan—type 2 diabetes mellitus	0.000231	0.00217	CcSEcCtD
Metyrapone—Nausea—Orlistat—type 2 diabetes mellitus	0.000228	0.00214	CcSEcCtD
Metyrapone—Vomiting—Metformin—type 2 diabetes mellitus	0.000225	0.00211	CcSEcCtD
Metyrapone—Headache—Metformin—type 2 diabetes mellitus	0.000222	0.00208	CcSEcCtD
Metyrapone—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000221	0.00207	CcSEcCtD
Metyrapone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00022	0.00207	CcSEcCtD
Metyrapone—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000213	0.002	CcSEcCtD
Metyrapone—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000212	0.00199	CcSEcCtD
Metyrapone—Nausea—Metformin—type 2 diabetes mellitus	0.00021	0.00197	CcSEcCtD
Metyrapone—Headache—Irbesartan—type 2 diabetes mellitus	0.000209	0.00196	CcSEcCtD
Metyrapone—Dizziness—Losartan—type 2 diabetes mellitus	0.000208	0.00195	CcSEcCtD
Metyrapone—Vomiting—Losartan—type 2 diabetes mellitus	0.0002	0.00188	CcSEcCtD
Metyrapone—Nausea—Irbesartan—type 2 diabetes mellitus	0.000198	0.00186	CcSEcCtD
Metyrapone—Headache—Losartan—type 2 diabetes mellitus	0.000197	0.00185	CcSEcCtD
Metyrapone—Nausea—Losartan—type 2 diabetes mellitus	0.000187	0.00175	CcSEcCtD
Metyrapone—Dizziness—Ramipril—type 2 diabetes mellitus	0.000178	0.00167	CcSEcCtD
Metyrapone—Vomiting—Ramipril—type 2 diabetes mellitus	0.000171	0.00161	CcSEcCtD
Metyrapone—Headache—Ramipril—type 2 diabetes mellitus	0.000169	0.00158	CcSEcCtD
Metyrapone—Nausea—Ramipril—type 2 diabetes mellitus	0.00016	0.0015	CcSEcCtD
Metyrapone—CYP2E1—Metabolism—STAR—type 2 diabetes mellitus	1.72e-05	0.000148	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP2E1—type 2 diabetes mellitus	1.71e-05	0.000147	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HK1—type 2 diabetes mellitus	1.7e-05	0.000147	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—APOA1—type 2 diabetes mellitus	1.7e-05	0.000146	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—SLC2A1—type 2 diabetes mellitus	1.69e-05	0.000146	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP1A2—type 2 diabetes mellitus	1.69e-05	0.000146	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CD36—type 2 diabetes mellitus	1.68e-05	0.000145	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.66e-05	0.000143	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP3A4—type 2 diabetes mellitus	1.65e-05	0.000142	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LPA—type 2 diabetes mellitus	1.65e-05	0.000142	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.65e-05	0.000142	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.65e-05	0.000142	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GCKR—type 2 diabetes mellitus	1.65e-05	0.000142	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCC8—type 2 diabetes mellitus	1.65e-05	0.000142	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CBS—type 2 diabetes mellitus	1.65e-05	0.000142	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.64e-05	0.000141	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GCG—type 2 diabetes mellitus	1.62e-05	0.00014	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—SLC2A4—type 2 diabetes mellitus	1.62e-05	0.00014	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—MTHFR—type 2 diabetes mellitus	1.59e-05	0.000137	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—COX2—type 2 diabetes mellitus	1.58e-05	0.000136	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.58e-05	0.000136	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALDOB—type 2 diabetes mellitus	1.58e-05	0.000136	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PPARA—type 2 diabetes mellitus	1.56e-05	0.000134	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NCOA6—type 2 diabetes mellitus	1.56e-05	0.000134	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—UCP2—type 2 diabetes mellitus	1.53e-05	0.000132	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.53e-05	0.000132	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—UCP3—type 2 diabetes mellitus	1.53e-05	0.000132	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AGT—type 2 diabetes mellitus	1.51e-05	0.00013	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PPARG—type 2 diabetes mellitus	1.5e-05	0.000129	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CALM1—type 2 diabetes mellitus	1.49e-05	0.000128	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOE—type 2 diabetes mellitus	1.48e-05	0.000128	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—INS—type 2 diabetes mellitus	1.47e-05	0.000126	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GLP1R—type 2 diabetes mellitus	1.47e-05	0.000126	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOA1—type 2 diabetes mellitus	1.47e-05	0.000126	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PCK1—type 2 diabetes mellitus	1.44e-05	0.000124	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.4e-05	0.00012	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GNB3—type 2 diabetes mellitus	1.4e-05	0.00012	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—HMOX1—type 2 diabetes mellitus	1.39e-05	0.00012	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CAT—type 2 diabetes mellitus	1.37e-05	0.000118	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.37e-05	0.000118	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ALB—type 2 diabetes mellitus	1.35e-05	0.000116	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HK1—type 2 diabetes mellitus	1.35e-05	0.000116	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CPT1A—type 2 diabetes mellitus	1.34e-05	0.000115	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTR—type 2 diabetes mellitus	1.34e-05	0.000115	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOB—type 2 diabetes mellitus	1.33e-05	0.000115	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.33e-05	0.000114	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NAMPT—type 2 diabetes mellitus	1.32e-05	0.000113	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LIPC—type 2 diabetes mellitus	1.31e-05	0.000112	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HBA1—type 2 diabetes mellitus	1.31e-05	0.000112	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GCK—type 2 diabetes mellitus	1.31e-05	0.000112	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LPA—type 2 diabetes mellitus	1.3e-05	0.000112	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GCKR—type 2 diabetes mellitus	1.3e-05	0.000112	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.3e-05	0.000112	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.3e-05	0.000112	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.3e-05	0.000112	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTM1—type 2 diabetes mellitus	1.3e-05	0.000112	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PPARG—type 2 diabetes mellitus	1.29e-05	0.000111	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.29e-05	0.000111	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—NOS3—type 2 diabetes mellitus	1.29e-05	0.000111	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.28e-05	0.00011	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—LPL—type 2 diabetes mellitus	1.27e-05	0.00011	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—INS—type 2 diabetes mellitus	1.27e-05	0.000109	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CETP—type 2 diabetes mellitus	1.26e-05	0.000109	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALDOB—type 2 diabetes mellitus	1.25e-05	0.000107	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ADCY5—type 2 diabetes mellitus	1.25e-05	0.000107	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GPX1—type 2 diabetes mellitus	1.24e-05	0.000107	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CD36—type 2 diabetes mellitus	1.21e-05	0.000104	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.2e-05	0.000103	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTGS2—type 2 diabetes mellitus	1.18e-05	0.000101	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PSMD6—type 2 diabetes mellitus	1.17e-05	0.000101	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SNAP25—type 2 diabetes mellitus	1.17e-05	0.000101	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SREBF1—type 2 diabetes mellitus	1.17e-05	0.000101	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.16e-05	9.99e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.16e-05	9.99e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ALB—type 2 diabetes mellitus	1.16e-05	9.99e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GLP1R—type 2 diabetes mellitus	1.16e-05	9.97e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CTGF—type 2 diabetes mellitus	1.15e-05	9.9e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MTHFR—type 2 diabetes mellitus	1.15e-05	9.87e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HMGCR—type 2 diabetes mellitus	1.14e-05	9.81e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPARA—type 2 diabetes mellitus	1.13e-05	9.68e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.12e-05	9.6e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NOS3—type 2 diabetes mellitus	1.11e-05	9.56e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.11e-05	9.56e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.1e-05	9.47e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.1e-05	9.47e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AGT—type 2 diabetes mellitus	1.09e-05	9.37e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.08e-05	9.31e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.07e-05	9.23e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CALM1—type 2 diabetes mellitus	1.07e-05	9.22e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOE—type 2 diabetes mellitus	1.07e-05	9.19e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.06e-05	9.12e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.06e-05	9.12e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CPT1A—type 2 diabetes mellitus	1.06e-05	9.12e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTR—type 2 diabetes mellitus	1.06e-05	9.12e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOA1—type 2 diabetes mellitus	1.06e-05	9.08e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.05e-05	9.04e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NAMPT—type 2 diabetes mellitus	1.04e-05	8.95e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.03e-05	8.9e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GCK—type 2 diabetes mellitus	1.03e-05	8.89e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HBA1—type 2 diabetes mellitus	1.03e-05	8.89e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LIPC—type 2 diabetes mellitus	1.03e-05	8.89e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.03e-05	8.83e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GCG—type 2 diabetes mellitus	1.02e-05	8.75e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.02e-05	8.75e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.02e-05	8.74e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.01e-05	8.68e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CETP—type 2 diabetes mellitus	9.97e-06	8.58e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	9.7e-06	8.34e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	9.7e-06	8.34e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	9.36e-06	8.06e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	9.36e-06	8.06e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	9.36e-06	8.06e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.36e-06	8.06e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	9.36e-06	8.06e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPARG—type 2 diabetes mellitus	9.3e-06	8e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SREBF1—type 2 diabetes mellitus	9.27e-06	7.97e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SNAP25—type 2 diabetes mellitus	9.27e-06	7.97e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PSMD6—type 2 diabetes mellitus	9.27e-06	7.97e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—INS—type 2 diabetes mellitus	9.12e-06	7.85e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CTGF—type 2 diabetes mellitus	9.1e-06	7.83e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	9.07e-06	7.8e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HMGCR—type 2 diabetes mellitus	9.01e-06	7.76e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	8.82e-06	7.59e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.76e-06	7.54e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GNB3—type 2 diabetes mellitus	8.76e-06	7.54e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HMOX1—type 2 diabetes mellitus	8.72e-06	7.51e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CAT—type 2 diabetes mellitus	8.61e-06	7.41e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.56e-06	7.37e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8.56e-06	7.37e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.38e-06	7.21e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.38e-06	7.21e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALB—type 2 diabetes mellitus	8.36e-06	7.19e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOB—type 2 diabetes mellitus	8.36e-06	7.19e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	8.35e-06	7.18e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.17e-06	7.03e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTM1—type 2 diabetes mellitus	8.13e-06	6.99e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.04e-06	6.91e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	8.04e-06	6.91e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NOS3—type 2 diabetes mellitus	8e-06	6.88e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3R1—type 2 diabetes mellitus	8e-06	6.88e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LPL—type 2 diabetes mellitus	7.98e-06	6.86e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.96e-06	6.85e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.96e-06	6.85e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.96e-06	6.85e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ADCY5—type 2 diabetes mellitus	7.81e-06	6.72e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GPX1—type 2 diabetes mellitus	7.78e-06	6.7e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.63e-06	6.57e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.63e-06	6.57e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	7.58e-06	6.52e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	7.49e-06	6.44e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.35e-06	6.32e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.35e-06	6.32e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTGS2—type 2 diabetes mellitus	7.32e-06	6.29e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.22e-06	6.21e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	7.18e-06	6.18e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.1e-06	6.11e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.1e-06	6.11e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.1e-06	6.11e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	7.05e-06	6.06e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	6.93e-06	5.96e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.93e-06	5.96e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	6.89e-06	5.93e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	6.83e-06	5.87e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	6.8e-06	5.85e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	6.71e-06	5.77e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	6.69e-06	5.75e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.67e-06	5.74e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	6.61e-06	5.69e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	6.6e-06	5.68e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	6.42e-06	5.53e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	6.31e-06	5.42e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.25e-06	5.38e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	6.17e-06	5.31e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	6.15e-06	5.29e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.03e-06	5.19e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.03e-06	5.19e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.03e-06	5.19e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.03e-06	5.19e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	5.99e-06	5.15e-05	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKT1—type 2 diabetes mellitus	5.93e-06	5.1e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.92e-06	5.09e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	5.83e-06	5.01e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.79e-06	4.98e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	5.71e-06	4.92e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	5.68e-06	4.88e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	5.57e-06	4.79e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	5.39e-06	4.64e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.38e-06	4.63e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	5.3e-06	4.56e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	5.29e-06	4.55e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	5.24e-06	4.51e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	5.22e-06	4.49e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKT1—type 2 diabetes mellitus	5.11e-06	4.39e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.02e-06	4.32e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.01e-06	4.31e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	5.01e-06	4.31e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.92e-06	4.23e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.92e-06	4.23e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.82e-06	4.15e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.79e-06	4.12e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.79e-06	4.12e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.79e-06	4.12e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.76e-06	4.1e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.68e-06	4.03e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.62e-06	3.98e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	4.6e-06	3.96e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	4.58e-06	3.94e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	4.52e-06	3.88e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.3e-06	3.7e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.3e-06	3.7e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.3e-06	3.7e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.22e-06	3.63e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.18e-06	3.6e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	4.14e-06	3.56e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.09e-06	3.52e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	3.96e-06	3.41e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.96e-06	3.41e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.93e-06	3.38e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.89e-06	3.35e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.89e-06	3.35e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.73e-06	3.21e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.73e-06	3.21e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKT1—type 2 diabetes mellitus	3.68e-06	3.16e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	3.62e-06	3.12e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.21e-06	2.76e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.21e-06	2.76e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.2e-06	2.75e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.16e-06	2.72e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.06e-06	2.64e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.98e-06	2.56e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.93e-06	2.52e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.86e-06	2.46e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.85e-06	2.46e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.78e-06	2.39e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.74e-06	2.36e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.63e-06	2.27e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.58e-06	2.22e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.5e-06	2.15e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.46e-06	2.12e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.45e-06	2.11e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.42e-06	2.09e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	2.3e-06	1.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.14e-06	1.84e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.09e-06	1.8e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.92e-06	1.65e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-06	1.58e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-06	1.58e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.82e-06	1.57e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-06	1.45e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.44e-07	7.27e-06	CbGpPWpGaD
